Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 322

1.
2.
3.

Molecular features of colorectal hyperplastic polyps and sessile serrated adenoma/polyps from Korea.

Kim KM, Lee EJ, Ha S, Kang SY, Jang KT, Park CK, Kim JY, Kim YH, Chang DK, Odze RD.

Am J Surg Pathol. 2011 Sep;35(9):1274-86. doi: 10.1097/PAS.0b013e318224cd2e.

PMID:
21836485
4.

Hyperplastic (serrated) polyps of the colorectum: relationship of CpG island methylator phenotype and K-ras mutation to location and histologic subtype.

O'Brien MJ, Yang S, Clebanoff JL, Mulcahy E, Farraye FA, Amorosino M, Swan N.

Am J Surg Pathol. 2004 Apr;28(4):423-34.

PMID:
15087661
5.

Improved molecular classification of serrated lesions of the colon by immunohistochemical detection of BRAF V600E.

Mesteri I, Bayer G, Meyer J, Capper D, Schoppmann SF, von Deimling A, Birner P.

Mod Pathol. 2014 Jan;27(1):135-44. doi: 10.1038/modpathol.2013.126. Epub 2013 Jul 26.

6.

BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis?

Velho S, Moutinho C, Cirnes L, Albuquerque C, Hamelin R, Schmitt F, Carneiro F, Oliveira C, Seruca R.

BMC Cancer. 2008 Sep 9;8:255. doi: 10.1186/1471-2407-8-255.

7.

The serrated neoplasia pathway of colorectal tumors: Identification of MUC5AC hypomethylation as an early marker of polyps with malignant potential.

Renaud F, Mariette C, Vincent A, Wacrenier A, Maunoury V, Leclerc J, Coppin L, Crépin M, Van Seuningen I, Leteurtre E, Buisine MP.

Int J Cancer. 2016 Mar 15;138(6):1472-81. doi: 10.1002/ijc.29891. Epub 2015 Oct 30.

8.

Intermediate serrated polyp as an intermediate lesion of hyperplastic polyp and sessile serrated polyp/adenoma in terms of morphological and molecular features.

Kwon HJ, Cho NY, Chang MS, Kim YS, Kang GH.

Hum Pathol. 2014 Aug;45(8):1759-65. doi: 10.1016/j.humpath.2014.04.014. Epub 2014 May 9.

PMID:
24935059
9.

A clinicopathological and molecular analysis of 200 traditional serrated adenomas.

Bettington ML, Walker NI, Rosty C, Brown IS, Clouston AD, McKeone DM, Pearson SA, Klein K, Leggett BA, Whitehall VL.

Mod Pathol. 2015 Mar;28(3):414-27. doi: 10.1038/modpathol.2014.122. Epub 2014 Sep 12.

10.

BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum.

Kambara T, Simms LA, Whitehall VL, Spring KJ, Wynter CV, Walsh MD, Barker MA, Arnold S, McGivern A, Matsubara N, Tanaka N, Higuchi T, Young J, Jass JR, Leggett BA.

Gut. 2004 Aug;53(8):1137-44.

11.

Serrated pathway in colorectal carcinogenesis.

Yamane L, Scapulatempo-Neto C, Reis RM, Guimarães DP.

World J Gastroenterol. 2014 Mar 14;20(10):2634-40. doi: 10.3748/wjg.v20.i10.2634. Review.

12.

Phenotype and polyp landscape in serrated polyposis syndrome: a series of 100 patients from genetics clinics.

Rosty C, Buchanan DD, Walsh MD, Pearson SA, Pavluk E, Walters RJ, Clendenning M, Spring KJ, Jenkins MA, Win AK, Hopper JL, Sweet K, Frankel WL, Aronson M, Gallinger S, Goldblatt J, Woodall S, Arnold J, Walker NI, Jass JR, Parry S, Young JP.

Am J Surg Pathol. 2012 Jun;36(6):876-82. doi: 10.1097/PAS.0b013e31824e133f.

13.

Distinct CpG island methylation profiles and BRAF mutation status in serrated and adenomatous colorectal polyps.

Kim YH, Kakar S, Cun L, Deng G, Kim YS.

Int J Cancer. 2008 Dec 1;123(11):2587-93. doi: 10.1002/ijc.23840.

14.

Morphologic and molecular characterization of traditional serrated adenomas of the distal colon and rectum.

Wiland HO 4th, Shadrach B, Allende D, Carver P, Goldblum JR, Liu X, Patil DT, Rybicki LA, Pai RK.

Am J Surg Pathol. 2014 Sep;38(9):1290-7. doi: 10.1097/PAS.0000000000000253.

PMID:
25127095
15.

Tracing origin of serrated adenomas with BRAF and KRAS mutations.

Lee EJ, Choi C, Park CK, Maeng L, Lee J, Lee A, Kim KM.

Virchows Arch. 2005 Sep;447(3):597-602. Epub 2005 Jul 1.

PMID:
15991007
16.

BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas.

Chan TL, Zhao W, Leung SY, Yuen ST; Cancer Genome Project..

Cancer Res. 2003 Aug 15;63(16):4878-81.

17.

KRAS and BRAF mutations and MSI status in precursor lesions of colorectal cancer detected by colonoscopy.

Yamane LS, Scapulatempo-Neto C, Alvarenga L, Oliveira CZ, Berardinelli GN, Almodova E, Cunha TR, Fava G, Colaiacovo W, Melani A, Fregnani JH, Reis RM, Guimarães DP.

Oncol Rep. 2014 Oct;32(4):1419-26. doi: 10.3892/or.2014.3338. Epub 2014 Jul 18.

PMID:
25050586
18.

MicroRNA-31 expression in relation to BRAF mutation, CpG island methylation and colorectal continuum in serrated lesions.

Ito M, Mitsuhashi K, Igarashi H, Nosho K, Naito T, Yoshii S, Takahashi H, Fujita M, Sukawa Y, Yamamoto E, Takahashi T, Adachi Y, Nojima M, Sasaki Y, Tokino T, Baba Y, Maruyama R, Suzuki H, Imai K, Yamamoto H, Shinomura Y.

Int J Cancer. 2014 Dec 1;135(11):2507-15. doi: 10.1002/ijc.28920. Epub 2014 Apr 30.

19.

Molecular and histologic considerations in the assessment of serrated polyps.

Yang HM, Mitchell JM, Sepulveda JL, Sepulveda AR.

Arch Pathol Lab Med. 2015 Jun;139(6):730-41. doi: 10.5858/arpa.2014-0424-RA. Review.

PMID:
26030242
20.

Supplemental Content

Support Center